Illinois 104th General Assembly Status: Introduced 2 D cosponsors

SB1258      — PRIOR AUTH-PRESCRIPTION DRUGS

Last action — Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced January 28, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.

Bill Text

We don't have the full text on file for this bill yet.

Read SB1258 on the official Illinois source →

Action History

  1. Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments

  2. Rule 3-9(a) / Re-referred to Assignments

  3. Rule 2-10 Committee Deadline Established As March 27, 2026

  4. Senate Committee Amendment No. 1 Assignments Refers to Insurance

  5. Senate Committee Amendment No. 1 Referred to Assignments

  6. Senate Committee Amendment No. 1 Filed with Secretary by Sen. Graciela Guzmán

  7. Re-assigned to Insurance

  8. Rule 3-9(a) / Re-referred to Assignments

  9. Rule 2-10 Committee/3rd Reading Deadline Established As May 9, 2025

  10. Rule 2-10 Committee Deadline Established As April 11, 2025

  11. Rule 2-10 Committee Deadline Established As April 4, 2025

  12. Assigned to Insurance

  13. Added as Co-Sponsor Sen. Rachel Ventura

  14. Referred to Assignments

  15. First Reading

  16. Filed with Secretary by Sen. Graciela Guzmán

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 1 co-sponsors · 181 not signed on

Sponsors (1)

Co-sponsors (1)

Not signed on (181)

181 members have not signed on to this bill.

Show all 181 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB1258      do?
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.
Who sponsors SB1258     ?
SB1258      is sponsored by Graciela Guzmán (Democrat) and Rachel Ventura (Democrat).
What is the current status of SB1258     ?
This bill has been introduced in the Senate. Introduced January 28, 2025. It must pass committee before a floor vote.
Where can I track SB1258     ?
Track SB1258      free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB1258     

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB1258     

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →